Company Analysis

ARS Pharmaceuticals, Inc. (SPRY)

Nasdaq: SPRY · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2016
Grade5.0
◀ Past 5.7● Present 5.4▶ Future 3.8
1 est.

Filings

207 filings since 2017 beside 340 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 29, 2026.

Filings a yearinsider forms included
2633097641477469
20182020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Jul 17, 2026.SEC letters: 3 in the last 36 months, the newest Nov 25, 2024.
Insider forms 340

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 27, 2026 SCHEDULE 13G Large holder notice
Jul 17, 2026 8-K item 5.02 Officer or director change · Current report Jul 15, 2026
Jul 14, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 7, 2026 8-K item 5.02 Officer or director change · Current report Jul 6, 2026
Jun 25, 2026 8-K item 5.07 Shareholder vote · Current report Jun 24, 2026
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 15, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 13, 2026 8-K items 5.02, 9.01 Officer or director change · Current report May 12, 2026
Apr 29, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 29, 2026 DEFA14A Extra proxy material
Apr 29, 2026 DEF 14A Proxy statement Jun 24, 2026
Apr 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 31, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 24, 2026 SCHEDULE 13G Large holder notice
Mar 9, 2026 S-8 Employee stock plan registration
Mar 9, 2026 10-K Annual report Dec 31, 2025
Mar 9, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 13, 2026 SCHEDULE 13G Large holder notice
Jan 21, 2026 SCHEDULE 13G Large holder notice
Nov 10, 2025 10-Q Quarterly report Sep 30, 2025
Nov 10, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 1, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 29, 2025 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report
Aug 28, 2025 8-K item 8.01 Other event · Current report Aug 13, 2025
Aug 13, 2025 10-Q Quarterly report Jun 30, 2025
Aug 13, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 1, 2025 SCHEDULE 13D/A Activist holder update, amended
Jul 22, 2025 SCHEDULE 13D/A Activist holder update, amended
Jul 2, 2025 SCHEDULE 13D/A Activist holder update, amended
Jun 26, 2025 8-K item 5.07 Shareholder vote · Current report Jun 25, 2025
May 14, 2025 10-Q Quarterly report Mar 31, 2025
May 14, 2025 8-K items 2.02, 9.01 Results released · Current report
May 2, 2025 8-K item 1.01 Major agreement signed · Current report
Apr 29, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 29, 2025 DEFA14A Extra proxy material
40 of 207 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton SPRY · research, not advice